COVID-19 Cases Surge Across the United States, Peak Rates in Southwest Amid School Reopenings

COVID-19 cases are surging across the U.S., with the highest rates in the Southwest, driven by the new 'Stratus' variant amid school reopenings and vaccination policy debates.
Recent data from the U.S. Centers for Disease Control and Prevention indicate a significant increase in COVID-19 cases nationwide, with the highest infection rates observed in the Southwestern United States. The region reports a virus prevalence of 12.5%, the highest among all states, coinciding with the period when schools in California and neighboring states are reopening for the new academic year.
Los Angeles County has recorded the highest levels of COVID-19 detected in wastewater since February, suggesting a possible rise in infections even among asymptomatic individuals. The resurgence is largely fueled by the emergence of the highly contagious 'Stratus' variant, which was first identified in Asia early this year. Reaching the U.S. in March, it quickly became the dominant strain, now representing approximately two-thirds of all detected COVID-19 variants in wastewater, according to CDC data.
The overall positivity rate of COVID-19 in the U.S. has climbed to 9% in early August, surpassing levels from the post-holiday winter surge but remaining below last August's peak of 18%. Meanwhile, weekly death rates have so far remained relatively low, although health experts warn that increasing infections could lead to a future rise in hospitalizations.
The variant's rapid spread complicates efforts to control the virus, particularly as public health authorities debate vaccination policies. Notably, the CDC no longer recommends updated COVID-19 booster shots for healthy children and pregnant women, a decision announced in May by Health and Human Services Secretary Robert F. Kennedy Jr. This move has faced criticism from many health organizations, including the American Academy of Pediatrics and the American Public Health Association, which argue that the decision lacks a sound scientific basis.
The CDC and infectious disease experts continue to emphasize that COVID-19 mutations, such as Stratus, evolve to transmit more efficiently and evade immunity from previous infections or vaccinations. Despite concerns, current data suggest that vaccination with booster doses remains beneficial, with the CDC’s own findings showing a 44% reduction in hospitalization and a 23% decrease in death risk among vaccinated individuals during the previous season.
However, vaccination rates for the 2024-2025 season currently lag, with only about 23% of adults and 13% of children receiving the updated booster shots, compared to roughly half of the population receiving the annual flu vaccine. This gap underscores ongoing challenges in achieving widespread immunity amidst evolving virus variants.
As schools reopen, public health officials urge caution and advocate for continued preventive measures, including vaccination and mask-wearing, to mitigate the surge. Monitoring wastewater and clinical data remains essential for early detection of transmission trends and informing public health responses.
For more information, visit https://medicalxpress.com/news/2025-08-covid-surges-nationwide-highest-southwest.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Metformin Use Linked to Enhanced Longevity in Older Women
A new study finds that metformin use among postmenopausal women is linked to a 30% reduction in mortality before age 90, suggesting potential benefits for healthy aging and longevity.
Does Semaglutide Really Impact Vision? What the Latest Research Shows
Recent research shows that semaglutide, a popular GLP-1 medication, is not definitively linked to eye disorders like diabetic retinopathy or vision loss. Learn more about the latest findings and what they mean for patients.
Real-World Data Demonstrates Benefits of Teclistamab for Diverse Multiple Myeloma Patients
New real-world evidence shows that teclistamab can provide meaningful benefits to a broader range of multiple myeloma patients, including those with high-risk features and previous therapies, beyond the initial clinical trial population.
Pregnancy Outcomes in Autoinflammatory Diseases: Insights from Recent Research
Recent research sheds light on pregnancy outcomes in women with autoinflammatory diseases, emphasizing the importance of disease control and multidisciplinary care to improve maternal and fetal health. Read more about these crucial findings.